- Home
- GANX vs ALTO Comparison
GANX vs ALTO Comparison
Compare GANX & ALTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GANX
- ALTO
- Stock Information
- Founded
- GANX 2017
- ALTO 2003
- Country
- GANX United States
- ALTO United States
- Employees
- GANX N/A
- ALTO N/A
- Industry
- GANX Biotechnology: Pharmaceutical Preparations
- ALTO Major Chemicals
- Sector
- GANX Health Care
- ALTO Industrials
- Exchange
- GANX Nasdaq
- ALTO Nasdaq
- Market Cap
- GANX 79.8M
- ALTO 90.6M
- IPO Year
- GANX 2021
- ALTO N/A
- Fundamental
- Price
- GANX $1.76
- ALTO $1.05
- Analyst Decision
- GANX Strong Buy
- ALTO Strong Buy
- Analyst Count
- GANX 6
- ALTO 1
- Target Price
- GANX $8.00
- ALTO $5.50
- AVG Volume (30 Days)
- GANX 901.0K
- ALTO 241.3K
- Earning Date
- GANX 11-12-2025
- ALTO 11-05-2025
- Dividend Yield
- GANX N/A
- ALTO N/A
- EPS Growth
- GANX N/A
- ALTO N/A
- EPS
- GANX N/A
- ALTO N/A
- Revenue
- GANX N/A
- ALTO $933,137,000.00
- Revenue This Year
- GANX N/A
- ALTO N/A
- Revenue Next Year
- GANX N/A
- ALTO $7.53
- P/E Ratio
- GANX N/A
- ALTO N/A
- Revenue Growth
- GANX N/A
- ALTO N/A
- 52 Week Low
- GANX $1.41
- ALTO $0.76
- 52 Week High
- GANX $2.81
- ALTO $2.05
- Technical
- Relative Strength Index (RSI)
- GANX 43.08
- ALTO 45.36
- Support Level
- GANX $1.74
- ALTO $1.05
- Resistance Level
- GANX $2.08
- ALTO $1.12
- Average True Range (ATR)
- GANX 0.15
- ALTO 0.05
- MACD
- GANX -0.03
- ALTO -0.01
- Stochastic Oscillator
- GANX 5.26
- ALTO 20.00
About GANX Gain Therapeutics Inc.
Gain Therapeutics Inc is a biotechnology company developing novel small molecule therapeutics to treat diseases across several therapeutic areas, including, lysosomal storage disorders, central nervous system disorders, metabolic disorders, and oncology. The company's clinical-stage product candidate, GT-02287, is being developed for the treatment of GBA1 Parkinson's disease. The company uses its computational target and drug discovery platform, Magellan, to discover novel allosteric binding sites on proteins implicated in disease and to identify proprietary small molecules that bind these sites to modulate protein function and treat the underlying cause of the disease. Geographically, the company operates in Switzerland, Spain, the United States, and Australia.
About ALTO Alto Ingredients Inc.
Alto Ingredients Inc is a producer of specialty alcohols and essential ingredients. The company serves five markets: Health, Home and Beauty, Food and Beverage, Essential Ingredients, and Renewable Fuels. Its customers include food and beverage companies and consumer products manufacturers and distributors. The company operates under three segments: Marketing and distribution, Pekin Campus production, Western production, and Others.